Nuestro Servicio de Digestivo recibe el Premio Ciudad de Pontevedra 🙌
Un premio como este, de los ciudadanos a los que nos debemos, es un honor que supera con creces cualquier otro. Y un refuerzo extra para seguir avanzando e innovando todos juntos 💪
22.01.2025 22:44 — 👍 4 🔁 0 💬 1 📌 0
The greatest review written on liver biopsy: indications, interpretation, and its future
By Dr Purva Gopal and colleagues in HepCommJournal
Open access journals.lww.com/hepcomm/full...
#liversky #pathsky
09.01.2025 00:45 — 👍 34 🔁 12 💬 2 📌 0
Two maps, first showing the distribution of HBV infection worldwide and then showing the location of clinical trials. Trials are least representative of high burden settings, especially for Africa.
There is urgent need for clinical trials for #HBV in #Africa.
Studies must deliver:
1. Quick start-up
2. Site potential, access to participants
3. High quality research leading to impact
www.thelancet.com/journals/lan...
🧪 #HepSky #LiverSky @mariondelphin.bsky.social @crick.ac.uk
11.01.2025 12:10 — 👍 12 🔁 6 💬 0 📌 0
Un estudio revela que los datos utilizados para entrenar la #IA están concentrando el poder en manos de unas pocas empresas, creando un oligopolio alineado con los intereses y objetivos de corporaciones con fines lucrativos
www.technologyreview.es/s/16958/asi-...
30.12.2024 15:06 — 👍 1 🔁 3 💬 0 📌 0
An article caught my eye, which I suppose may be of interest due to the peculiarities of the US healthcare system
In Europe, it hasn't been necessary to be on the verge of achieving the WHO elimination goals
06.01.2025 18:06 — 👍 0 🔁 0 💬 0 📌 0
Admittedly the cool name of the study group first caught my 👁️
POSEIDON study group showed
✅alfapump 📉need for LVP
✅similar complications
✅improved QOL
@amcollegegastro.bsky.social
journals.lww.com/ajg/abstract...
#liversky
06.01.2025 16:44 — 👍 9 🔁 3 💬 0 📌 0
YouTube video by Maja Thiele
The three rules of biomarker appraisal
The three critical rules of biomarker appraisal:
✋Truthful? = analytical validity
👍Meaningful? = clinical validity
🙌Useful? = clinical utility
youtu.be/zCjxDeyXgfU?...
#liversky #biomarkers #medicine
06.01.2025 11:42 — 👍 21 🔁 7 💬 1 📌 0
The key may be in the selection. There are so many variables (types of surgery, types of decompensation) that it is impossible to address from a prospective study at this point in time. It may be worthwhile to have a registry to help glean what is futile versus what is possible.
05.01.2025 17:35 — 👍 2 🔁 1 💬 1 📌 0
Key recommendations in portal vein thrombosis in patients with cirrhosis:
✅Identify recent thrombosis and extent
✅Anticoagulate if recent & >50% obstruction
❌ No anticoagulants if chronic cavernomas
✅DOACs safe if compensated
🤏 TIPS sometimes
💡 Image every 3m
doi.org/10.1053/j.ga...
#LiverSky
05.01.2025 17:05 — 👍 9 🔁 4 💬 0 📌 0
Good point 😂
04.01.2025 19:39 — 👍 1 🔁 0 💬 0 📌 0
Interesting arguments, although the 4th would make for a good debate if you add the guys from the Clinic Hospital of Barcelona and the Ramón y Cajal of Madrid to the discussion 😉
Out of curiosity, what were the arguments of @brettefortune.bsky.social?
04.01.2025 19:35 — 👍 0 🔁 0 💬 1 📌 0
I once lost a debate in spectacular fashion to @brettefortune.bsky.social. Popular vote landslide AND electoral college
He was for early TIPS after variceal bleeding. I was against
My points were:
#liversky
04.01.2025 19:27 — 👍 9 🔁 3 💬 2 📌 0
Indeed, in the real world, the ability to place a TIPS at the most appropriate time for the patient is as important as selecting the patient who can benefit most from it. Two conditions that are rarely met ...
04.01.2025 19:31 — 👍 4 🔁 0 💬 1 📌 0
⚠️ A recent study in patients with cirrhosis and portal hypertension shows that preoperative placement of TIPS is associated with increased postoperative mortality 🤨
doi.org/10.1097/hc9....
#LiverSky #MedSky
04.01.2025 19:10 — 👍 15 🔁 5 💬 4 📌 1
Albumin is the closest thing to a "universal remedy" in cirrhosis
We use it to treat different complications, with good evidence but also with debatable or negative evidence
Excellent analysis by Jonel Trebicka & @ggarciatsao.bsky.social
doi.org/10.1097/hep.0000000000000521
#LiverSky
04.01.2025 11:10 — 👍 11 🔁 5 💬 0 📌 0
Incidence of cancer in PSC
#liversky
02.01.2025 01:57 — 👍 16 🔁 4 💬 1 📌 0
Decompensated cirrhosis has often been considered the irreversible, terminal stage of liver disease, but this is not actually always the case
Have you heard of the concept of cirrhosis "recompensation"?
➡️ doi.org/10.1016/j.jhepr.2024.101233
#LiverSky
03.01.2025 17:41 — 👍 6 🔁 4 💬 1 📌 0
Today marks the end of my journey as Associate Editor at Liver International. It’s been a fantastic experience, and I’m confident the journal will continue to grow 📈
I encourage researchers to submit their valuable work and contribute to its success!
#liverSky
01.01.2025 14:25 — 👍 13 🔁 1 💬 0 📌 0
⁉️ Crees que la implantación de la #IA generativa en tu trabajo es lenta o inexistente? @emollick.bsky.social lo explica en Co-Intelligence:
🚫 Exceso de centralización y burocracia
🐢 Estrategias obsoletas
🔑 El verdadero poder está en quienes conocen los problemas reales y ya están probando soluciones
30.12.2024 19:27 — 👍 0 🔁 0 💬 0 📌 0
Image Gallery : Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies : Hepatology Communications
Early Terli
Giving terlipressin at lower creatinines (1.5-2.0) or within 12 hours of presentation (skipping the “albumin challenge”)
1. From the RCTs journals.lww.com/hepcomm/page...
2. Pilot trial doi.org/10.1007/s106...
#liversky
23.12.2024 00:15 — 👍 18 🔁 7 💬 2 📌 0
Over on the Twitter I have liked hundreds of match day celebrations
Observations:
1. Bluesky still needs more value for learners and research discussions. It is growing but needs to be sustained
2. Match day reminds: America and American medicine still attracts the worlds best and brightest
08.12.2024 21:35 — 👍 13 🔁 4 💬 2 📌 0
What do hepatic encephalopathy and irritable bowel syndrome have in common?
Read this hot take from @jasmohanbajaj.bsky.social and @markpimentelmd.bsky.social in #AJG on whether HE is the original disorder of gut brain interaction (DGBI)
#GISky #LiverSky
Link: journals.lww.com/ajg/fulltext...
09.12.2024 18:00 — 👍 5 🔁 2 💬 0 📌 0
We’re serious about @bsky.app’s future 🤝
09.12.2024 14:26 — 👍 52 🔁 9 💬 1 📌 0
Locoregional Therapies for Hepatocellular Carcinoma
This systematic review and meta-analysis compares findings from randomized clinical trials on the use of locoregional therapies as monotherapy or combination therapy in the treatment of nonmetastatic ...
Systematic review & meta-analysis of locoregional therapies for #HCC in @jama.com network open
✅Inclusion:
RCTs with PFS and OS as endpoints
✅Conclusions:
Resection > thermal ablation ~ RT ~ HAIC > embolization
#oncsky #radonc #radsky #liversky
ja.ma/3ONRpQ1
06.12.2024 12:45 — 👍 19 🔁 7 💬 3 📌 0
Global Healthcare Services Manager @ Hyland | Passionate about healthcare, digital health, AI & cloud | BSc, PRINCE2, MSP, L6σ Green Belt | Opinions are my own | https://linktr.ee/paulcochrane
Dr. Joaquin Cabezas, MD. Gastroenterologist and Hepatologist. University Hospital Marques de Valdecilla- IDIVAL. Santander. Spain. www.digestivovaldecilla.com
GI Doc, Asst Professor. Interests include medicine, politics, basketball, soccer, hockey, board games, video games, sci-fi/fantasy, drumming, music. Sarcasm gets me in trouble. Very liberal. He/Him BLM #GISky #LiverSky #GastroSky #MedSky 🇨🇦 🇺🇸 🇧🇷
Transplant Hepatologist at University Hospitals. Assistant Professor of Medicine at CWRU School of Medicine. Interested in all things #LiverSky.
Transplant Hepatologist at Washington University School of Medicine in St Louis. Liver tumors focus. #runner. Views are my own.
GI-hep fellow UMD/ NIH. IM residency @MedStar WHC/Georgetown. 2021 AASLD ELS🏆. Alum KEM, Mumbai.
Off to MD for the next phase.
Focused on Gastrointestinal #GI Oncology at the Prince of Wales Hospital #CUHKMedicine 🇭🇰 with interests in cancer #genetics, #irAE and gut microbiota
ELC Co-Chair #APAGE • #ASCO LDP APAC Class 21-22 • #ESMO LGP Asia Class 23-24
🔗 https://g.co/kgs/gU3BvBn
Dislocated Canadian GI doc now living and working in South Bay, CA. Husband and dad of 3. Follow me for thoughts on healthcare systems, left leaning political reflections, sportball opinions and tv hot takes.
MD PhD. Hepatology researcher. Odense Liver Research Center. EASL YI Task Force.
Physician scientist at Stanford University
Passionate about liver cancer research
Transplant Hepatologist
Co-Founder Arithmedics
Academic Gastroenterologist and Clinical Trialist
Husband since 1995, father of 3, hepatologist caring for patients and research. Posts are mine. he/his
Research group led by Benjamin Maasoumy
📍Hannover Medical School, Germany.
Clinician scientists & doctoral students researching liver cirrhosis, its complications & hepatitis. Follow along for research, news and publications.
A-TANGO, an EU-funded Horizon2020 research consortium, is conducting Phase II #clinical studies of an innovative therapeutic strategy called G-TAK to fight advanced #cirrhosis and acute-on-chronic #LiverFailure, aka #ACLF.
🌐 https://a-tango.eu
Rural full spectrum family doctor doing it all in Minnesota. Posts are my own, not my employer's. Family planning, rural OB, hepatitis C/B/HIV, TB, and addiction med focus. Queer, out, proud.
We act as the united and trusted voice of European gastroenterology and are recognised as the leading authority for digestive health.